Who has been buying iQuest stock?

1 distinct insiders have filed 1 disclosed insider purchases in iQuest (262840), most recently on 2026-04-16. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does iQuest have?

iQuest has 1 buy-side and 0 sell-side disclosures on record, covering ₩2M ($2K) in total reported value, spanning 2024-04-19 to 2026-04-16.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

iQuest 262840

Company

아이퀘스트iQuest

Insiders

Buys

Total Value

₩2M ($2K)

Avg Return

-21.73%

Last Filing

2026-04-16

iQuest (262840) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩2M ($2K) in reported transaction value. The earliest filing StockDrifts holds for iQuest is dated 2024-04-19; the most recent is 2026-04-16. Across these filings the average return since disclosure is -21.73%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-04-16	SELL	주식병합	김순모 Soonmo Kim	CEO	-3.9M	₩1,780	+0.0%	₩7.0B ($4.8M)
2026-04-16	SELL	주식병합	박원일 Park Won-il	CEO	-20.7K	₩1,780	+0.0%	₩37M ($26K)
2026-04-16	SELL	주식병합	성병직 venereal disease	vice president	-107.8K	₩1,780	+0.0%	₩192M ($133K)
2025-04-29	BUY	무상신주취득	박원일 Park Won-il	vice president	3.8K	₩2,240	-23.4%	₩8M ($6K)
2025-04-29	BUY	무상신주취득	성병직 venereal disease	vice president	19.6K	₩2,240	-23.4%	₩44M ($30K)
2025-04-29	BUY	무상신주취득	김순모 Soonmo Kim	CEO	710.2K	₩2,240	-23.4%	₩1.6B ($1.1M)
2025-02-28	BUY	Market Buy	박원일 Park Won-il	vice president	1.0K	₩2,191	-21.7%	₩2M ($2K)
2024-07-31	SELL	임원퇴임	이병주 Lee Byung-ju	Managing Director	-196.0K	₩2,159	+20.6%	₩423M ($294K)
2024-04-19	BUY	무상신주취득	박원일 Park Won-il	vice president	18.3K	₩3,474	-50.6%	₩64M ($44K)
2024-04-19	BUY	무상신주취득	이병주 Lee Byung-ju	Managing Director	98.0K	₩3,474	-50.6%	₩340M ($236K)
2024-04-19	BUY	무상신주취득	성병직 venereal disease	Managing Director	98.0K	₩3,474	-50.6%	₩340M ($236K)
2024-04-19	BUY	무상신주취득	김순모 Soonmo Kim	CEO	3.6M	₩3,474	-50.6%	₩12.3B ($8.6M)

Frequently asked questions

Who has been buying iQuest stock?: 1 distinct insiders have filed 1 disclosed insider purchases in iQuest (262840), most recently on 2026-04-16. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does iQuest have?: iQuest has 1 buy-side and 0 sell-side disclosures on record, covering ₩2M ($2K) in total reported value, spanning 2024-04-19 to 2026-04-16.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.